dc.contributor.author | Iraz, Meryem | |
dc.contributor.author | Düzgün, Azer Özad | |
dc.contributor.author | Çiçek, Ayşegül Çopur | |
dc.contributor.author | Bonnin, Remy A. | |
dc.contributor.author | Ceylan, Ayşenur | |
dc.contributor.author | Saral, Ayşegül | |
dc.contributor.author | Nordmann, Patrice | |
dc.contributor.author | Sandalli, Cemal | |
dc.date.accessioned | 2020-12-19T20:03:23Z | |
dc.date.available | 2020-12-19T20:03:23Z | |
dc.date.issued | 2014 | |
dc.identifier.citation | Iraz, M., Duzgun, A.O., Cicek, A.C., Bonnin, R.A., Ceylan, A., Saral, A., Nordmann, P. ve diğerleri (2014). Characterization of novel VIM carbapenemase, VIM-38, and first detection of GES-5 carbapenem-hydrolyzing beta-lactamases in Pseudomonas aeruginosa in Turkey. Diagnostic Microbiology and Infectious Disease, 78(3), 292-294. https://doi.org/10.1016/j.diagmicrobio.2013.12.003 | en_US |
dc.identifier.issn | 0732-8893 | |
dc.identifier.issn | 1879-0070 | |
dc.identifier.uri | https://doi.org/10.1016/j.diagmicrobio.2013.12.003 | |
dc.identifier.uri | https://hdl.handle.net/11436/3155 | |
dc.description | DUZGUN, AZER OZAD/0000-0002-6301-611X; DUZGUN, AZER OZAD/0000-0002-6301-611X; Bonnin, Remy A./0000-0002-2307-3232; SANDALLI, Cemal/0000-0002-1298-3687 | en_US |
dc.description | WOS: 000332056500018 | en_US |
dc.description | PubMed: 24428980 | en_US |
dc.description.abstract | Pseudomonas aeruginosa isolates were collected form a Turkish hospital. Antimicrobial susceptibility was performed using the Vitek 2 Compact system, and 24 isolates were categorized as multidrug resistant (n = 18), extensively-drug resistant (n = 5), or pan-drug resistant (n = I). PCR and DNA sequence analysis revealed that 1 strain possessed the bla(GES-5) and another carried a novel bla(VIM) variant, named VIM-38. This new gene exhibited 1 amino acid substitution (Ala265Val) in comparison to its closest variant, VIM-5. Both VIM encoding genes were clones and demonstrated similar susceptibility profile when expressed in identical background. the presence of VIM-38 increases the diversity of carbapenemases in Turkey. (C) 2014 Elsevier Inc. All rights reserved. | en_US |
dc.description.sponsorship | Recep Tayyip Erdogan University Research FundRecep Tayyip Erdogan University [BAP-2012.106.01.11, BAP-2011.102.03.3] | en_US |
dc.description.sponsorship | This work was supported by Recep Tayyip Erdogan University Research Fund Grants BAP-2012.106.01.11 and BAP-2011.102.03.3. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Elsevier Science Inc | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Pseudomonas aeruginosa | en_US |
dc.subject | Carbapenemase | en_US |
dc.subject | beta-lactamase | en_US |
dc.subject | ESBL | en_US |
dc.subject | Class 1 integron | en_US |
dc.title | Characterization of novel VIM carbapenemase, VIM-38, and first detection of GES-5 carbapenem-hydrolyzing beta-lactamases in Pseudomonas aeruginosa in Turkey | en_US |
dc.type | article | en_US |
dc.contributor.department | RTEÜ, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü | en_US |
dc.contributor.institutionauthor | Çiçek, Ayşegül Çopur | |
dc.contributor.institutionauthor | Sandalli, Cemal | |
dc.identifier.doi | 10.1016/j.diagmicrobio.2013.12.003 | |
dc.identifier.volume | 78 | en_US |
dc.identifier.issue | 3 | en_US |
dc.identifier.startpage | 292 | en_US |
dc.identifier.endpage | 294 | en_US |
dc.relation.journal | Diagnostic Microbiology and Infectious Disease | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |